Biotech-Focused BCGF Registers $87M IPO

IPO

Newly formed BCGF Acquisition filed to offer 8.7 million units, each consisting of one share and a warrant.

BCGF is focused on the biotech sector. The SPAC in the filing said it will not consider any business in China, including Hong Kong and Macau.

CEO and Chairman Tassapon Bijleveld has served since 2007 as a director, and since 2018 as executive chairman, of Asia Aviation, a holding company investing in low-fare airlines and businesses. He was CEO of that company from 2007 to 2018.

EF Hutton is managing the offering.

The SPAC has applied for a Nasdaq listing under the symbol BCGFU. Read more.

Total
1
Shares
Related Posts